US Oncology Budget Analyst Salaries in Wilmington, DE | Comparably
US Oncology operates a network of integrated community-based oncology practices that provides cancer care services in the United States. read more
EMPLOYEE
PARTICIPANTS
80
TOTAL
RATINGS
550

US Oncology Budget Analyst Salaries in Wilmington, DE

The average US Oncology Budget Analyst in Wilmington, DE earns an estimated $79,807 annually. US Oncology's Budget Analyst compensation is $11,882 more than the US average for a Budget Analyst.

In Wilmington, DE, The Finance Department at US Oncology earns $16,645 more on average than the Admin Department.

Last updated 7 months ago.

$35k
$45k
$53k
$62k
$96k
$135k
$158k
$79,807
Average Compensation
$79,807
avg. base

Budget Analyst Salaries at US Oncology

In Wilmington, DE, Budget Analysts earn $9,073 more than Accountants, and $12,302 less than Senior Accountants.

Accounting Manager
$121k*
Business Analyst
$96k*
Senior Accountant
$92k*
Accountant
$71k*
Financial Analyst
$68k*
* estimated salary

Compensation at US Oncology by Department

In Wilmington, DE, The Finance Department averages $16,645 more than the Admin Department, and $10,806 less than the IT Department

IT
$95,561 Avg. total comp.
+$11k
Finance
$84,755 Avg. total comp.
Admin
$68,110 Avg. total comp.
-$17k

Budget Analyst Compensation by Gender (All Companies)

The average female Budget Analyst at companies similar size to US Oncology reported making $98,833, while the average male Budget Analyst at similar sized companies reported making $76,324.

Budget Analyst Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Budget Analyst at companies similar size to US Oncology reported making $101,500, while the average African American/Black Budget Analyst at similar sized companies reported making $70,000.

How Budget Analysts at US Oncology Rate Their Compensation

The majority of Budget Analysts at US Oncology believe they're compensated fairly. 50% of Budget Analysts at US Oncology say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at US Oncology

×
Rate your company